Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:315-320
Published online before print December 2, 2004, doi: 10.1161/01.ATV.0000152355.97808.10
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/2/315    most recent
01.ATV.0000152355.97808.10v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pini, B.
Right arrow Articles by FitzGerald, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pini, B.
Right arrow Articles by FitzGerald, G. A.
Related Collections
Right arrow Other Vascular biology
Right arrow Animal models of human disease
Right arrow Developmental biology
Right arrow Functional genomics
Right arrow Gene expression
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:315.)
© 2005 American Heart Association, Inc.


Vascular Biology

Prostaglandin E Synthases in Zebrafish

Barbara Pini; Tilo Grosser; John A. Lawson; Tom S. Price; Michael A. Pack; Garret A. FitzGerald

From the Institute for Translational Medicine and Therapeutics (B.P., T.G., J.A.L., T.S.P., G.A.F.) and the Department of Medicine, Gastroenterology Division (M.A.P.), University of Pennsylvania School of Medicine, Philadelphia.

Correspondence to Garret A. FitzGerald, MD, the Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, 153 Johnson-Pavilion, 3620 Hamilton Walk, Philadelphia, PA 19104-6084. E-mail garret{at}spirit.gcrc.upenn.edu

Objective— Prostaglandin E synthases (PGESs) are being explored as antiinflammtory drug targets as alternatives to cyclooxygenase (COX)-2. Located downstream of the cyclooxygenases, PGESs catalyze PGE2 formation, and deletion of microsomal (m)-PGES-1 abrogates inflammation. We sought to characterize the developmental expression of COX and PGES in zebrafish.

Methods and Results— We cloned zebrafish cytosolic (c) and m-PGES orthologs and mapped them to syntenic regions of chromosomes 23 and 5. cPGES was widely expressed during development and was coordinately regulated with zCOX-1 in the inner ear, the pronephros, and intestine. COX-2 and mPGES-1 exhibited restricted expression, dominantly in the vasculature of the aortic arch. However, the enzymes were anatomically segregated within the vessel wall. Experiments with antisense morpholinos and with nonsteroidal antiinflammatory drugs suggest that these genes may not be critical for development.

Conclusions— mPGES-1 is developmentally coregulated with COX-2 in vasculature. Given the high fecundidity and translucency of the zebrafish, this model may afford a high throughput system for characterization of novel PGES inhibitors.

Mircosomal prostaglandin E synthase (mPGES)-1, located downstream of COX-2, may represent a novel antiinflammatory drug target. Zebrafish cytosolic (c) PGES-1 and COX-1 were coordinately expressed; mPGES-1 and COX-2 were expressed particularly in the vasculature. Zebrafish may afford a high throughput system for detection of novel PGES inhibitors.


Key Words: prostaglandin E synthase • cyclooxygenase • zebrafish • Danio rerio • vascular biology




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
M. B. Lucitt, T. S. Price, A. Pizarro, W. Wu, A. K. Yocum, C. Seiler, M. A. Pack, I. A. Blair, G. A. FitzGerald, and T. Grosser
Analysis of the Zebrafish Proteome during Embryonic Development
Mol. Cell. Proteomics, May 1, 2008; 7(5): 981 - 994.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Wang, E. Lee, W. Song, E. Ricciotti, D. J. Rader, J. A. Lawson, E. Pure, and G. A. FitzGerald
Microsomal Prostaglandin E Synthase-1 Deletion Suppresses Oxidative Stress and Angiotensin II-Induced Abdominal Aortic Aneurysm Formation
Circulation, March 11, 2008; 117(10): 1302 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. Samuelsson, R. Morgenstern, and P.-J. Jakobsson
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
Pharmacol. Rev., September 1, 2007; 59(3): 207 - 224.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. S. Price, M. B. Lucitt, W. Wu, D. J. Austin, A. Pizarro, A. K. Yocum, I. A. Blair, G. A. FitzGerald, and T. Grosser
EBP, a Program for Protein Identification Using Multiple Tandem Mass Spectrometry Datasets
Mol. Cell. Proteomics, March 1, 2007; 6(3): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Wang, A. M. Zukas, Y. Hui, E. Ricciotti, E. Pure, and G. A. FitzGerald
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
PNAS, September 26, 2006; 103(39): 14507 - 14512.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. I. Cha, S.-H. Kim, D. Sepich, F. G. Buchanan, L. Solnica-Krezel, and R. N. DuBois
Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation
Genes & Dev., January 1, 2006; 20(1): 77 - 86.
[Abstract] [Full Text] [PDF]